Cat.#: ASSD-142
Description | Methoxy-X04 is a fluorescent substance that can pass through the blood-brain barrier (BBB). It is used to identify amyloid β deposits in the brain after death. When tested in a laboratory setting, it showed a strong attraction to amyloid beta fibrils (Ki = 26.87 nM). Additionally, the compound is active in vivo. |
Size | 10 mg, 50 mg |
Applications | For used to stain amyloid beta plaques, tangles and cerebrovascular amyloid. |
Chemical Name | 4,4'-[(2-methoxy-1,4-phenylene)di-(1E)-2,1-ethenediyl]bisphenol |
Molecule Weight | 344.4 |
Molecular formula | C23H20O3 |
CAS Number | 863918-78-9 |
PubChem identifier | 16049314 |
Purity | >98% |
Solubility | Soluble in DMSO (100 mM), and in ethanol (20 mM) |
Form | Yellow solid |
Storage | Store at 4° C |
Shipping | Shipped at 4°C |
Important | We strongly recommend storing this product away from light. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-119 | Fluorescent adenosine agonist [NECA] (AC119) | 500 μg | inquiry |
ASSD-105 | Hoechst 33342 (AC105) | 10 mg, 100 mg | inquiry |
ASSD-151 | Acid Fuchsin (AC151) | 25 g | inquiry |
ASSD-214 | 8-Aminopyrene-1,3,6-trisulfonic acid trisodium salt (AC214) | 10 mg | inquiry |
ASSD-177 | Fluorescein 5-Maleimide (AC177) | 25 mg | inquiry |
ASSD-102 | DAPI (AC102) | 10 mg, 50 mg | inquiry |
ASSD-228 | ImmunoHistoMount (AC228) | 30 ml | inquiry |
ASSD-107 | Modified Mayer's Hematoxylin (AC107) | 125 mL, 250 mL, 2×250mL | inquiry |
ASSD-143 | Fluorescently labeled Muscimol TMR-X conjugate (AC143) | 1mg | inquiry |
ASSD-190 | Chrysamine G Disodium Salt (AC190) | 10 mg, 25 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.